187. Kabuki syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 6 - (DrugBank : 2) / Drug target genes : 3 - Drug target pathways : 17
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Genotropin
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Intervention ON primary cultured cells
University Hospital, Montpellier
2020 - NCT03855631 France
Modified atkins diet
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
2021 Early Phase 1 NCT04722315 United States
Recombinant DNA-derived human growth hormone
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Risperidone
Child Psychopharmacology Institute
2008 - NCT00723580 United States
Somatropin
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Intervention ON primary cultured cells
University Hospital, Montpellier
2020 - NCT03855631 France
Modified atkins diet
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
2021 Early Phase 1 NCT04722315 United States
Recombinant DNA-derived human growth hormone
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands
Risperidone
Child Psychopharmacology Institute
2008 - NCT00723580 United States
Somatropin
Maastricht University Medical Centre
2012 - EUCTR2012-000432-26-NL Netherlands